Tissue World Magazine
Alexandra Stuthridge, Technical Business Manager, BioProducts Institute (BPI)

SCA has strengthened its cooperation with Vinda International by transferring its hygiene business in China (mainland China, Hong Kong and Macau) to Vinda.

As part of the transaction, SCA and Vinda have signed an agreement regarding the exclusive license to market and sell the SCA brands; TENA, (incontinence products) Tork (AfH tissue), Tempo (consumer tissue), Libero (baby diapers), and Libresse (feminine care) in China (mainland China, Hong Kong and Macau). With this agreement, Vinda will hold the rights to these product brands in these Chinese markets.

Vinda will acquire SCA’s Dr P and Sealer brands in China.

Jan Johansson, president and chief executive of SCA, said: “With its immense number of inhabitants, ageing population and low penetration of hygiene products, China is an attractive and important market with significant potential for future growth.

“This new cooperation and transaction will generate mutual benefits for both SCA and Vinda particularly in distribution, sales, innovation and R&D.

“Vinda will get access to a broader product portfolio and SCA’s brands will have the potential to reach a broader base of consumers and customers via the extensive and robust distribution network of Vinda in China.”

SCA has been a shareholder in Vinda since 2007 and it became its majority shareholder in late 2013.

SCA’s hygiene business in China (mainland China, Hong Kong and Macau) had net sales of approximately SEK 600m in 2013.
The purchase consideration amounts to HKD 1,144m on a debt-free basis.

The agreement is subject to approval by the independent shareholders of Vinda.